Polymorphism in miR-146a associated with clinical characteristics and outcomes in gastric cancer patients treated with adjuvant oxaliplatin and fluoropyrimidines.

Onco Targets Ther · 2015 · PMC4577269 · PMID 26396533

Europe PMC DOI

hedged sentence

0.0950

closest p · 1.9× alpha

0.0950

boldest claim

The sentences

borderline significantP =0.095so close (0.05 < p ≤ 0.1)

N stage revealed a borderline significant association with DFS ( P =0.095).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.